The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...

Agitation in dementia is often caused by brain changes and can worsen over time. Familiar routines and avoiding known triggers can help manage agitation. Caregivers should use nondrug strategies ...

While most people are familiar with Alzheimer’s disease, a progressive neurological disorder and the most common cause of dementia, it is often difficult to truly understand the common symptoms and ...

The FDA has approved the expanded use of Auvelity to treat adults with agitation associated with dementia due to Alzheimer disease.

Agitation is a neuropsychiatric symptom in patients with Alzheimer's disease (AD), the most common form of dementia. The prevalence of this symptom is about 40%-65% ...

Scientists have found a link between anxiety and dementia risk. Eloisa Ramos/Stocksy Past studies have also found a connection between anxiety and an increased risk for dementia. Now, researchers from ...

Approximately 6.5 million Americans and their loved ones, friends, and caregivers experience the distress associated with Alzheimer’s dementia. One of the most troubling symptoms associated with this ...

Please provide your email address to receive an email when new articles are posted on . Researchers reviewed 18 randomized clinical trials that recruited individuals with dementia and ...

Combative and agitated behavior in people with dementia is not rare. Managing this behavior is difficult. Research is limited but cannabis may be of help. The concepts of cannabis use in our society ...

Resources are available through the Center for Healthy Aging through Carilion’s home health services and through the ...

Please provide your email address to receive an email when new articles are posted on . Patients with chronic anxiety and new anxiety were approximately three times more likely to develop dementia.